Maccura Biotechnology Co Ltd
300463
Company Profile
Business description
Maccura Biotechnology Co Ltd is a China-based in-vitro diagnostic (IVD) integration company engaged in the research and development, production and sales of IVD products. It is also engaged in the sales of foreign brands of in vitro diagnostic products as an agent. The company's developed product and technology development platforms cover clinical biochemistry, chemiluminescent immunoassay, rapid diagnosis, thrombosis, hemostasis, and molecular diagnosis.
Contact
Number 8, 2nd Anhe Road
Hi-tech Zone
Chengdu611731
CHNT: +86 2881731888
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2024
Employees
3,362
Stocks News & Analysis
stocks
Should you invest in small caps?
With small capitalisation stocks gaining momentum, there are important considerations to determine whether they are right for your portfolio.
stocks
3 no moat companies that might surprise you
Moats are rare but worth looking for. These three ASX listed companies own iconic brands but don't make the cut according to our analysts.
stocks
Are investors too optimistic about ASX listed data centre provider?
Move to cloud and AI driving strong data centre industry demand.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,659.60 | 47.00 | 0.55% |
| CAC 40 | 7,194.51 | 62.96 | -0.87% |
| DAX 40 | 19,295.98 | 109.22 | -0.56% |
| Dow JONES (US) | 44,860.31 | 123.74 | 0.28% |
| FTSE 100 | 8,258.61 | 33.07 | -0.40% |
| HKSE | 19,422.99 | 263.79 | 1.38% |
| NASDAQ | 19,175.58 | 120.74 | 0.63% |
| Nikkei 225 | 38,134.97 | 307.03 | -0.80% |
| NZX 50 Index | 13,212.92 | 99.16 | 0.76% |
| S&P 500 | 6,021.63 | 34.26 | 0.57% |
| S&P/ASX 200 | 8,406.70 | 47.30 | 0.57% |
| SSE Composite Index | 3,299.03 | 39.28 | 1.20% |